Kentucky hemp founder warns new THC cap could hit full-spectrum CBD oils
A federal hemp rule taking effect Dec. 11 could push some full-spectrum CBD products outside the hemp definition if they exceed a new THC threshold. Kentucky Cannabis Company founder Bill Polyniak says the change could lump naturally derived extracts together with chemically converted intoxicating cannabinoids.
Why it matters: - A new federal THC limit could affect traditional full-spectrum CBD oils that contain naturally occurring trace amounts of THC. - The rule may reshape how hemp manufacturers, retailers and consumers distinguish between plant-derived extracts and chemically converted intoxicating cannabinoids. - Kentucky Cannabis Company founder Bill Polyniak says the change could have consequences for consumer safety, product labeling and the future of hemp.
What happened: - Federal hemp law changes scheduled for Dec. 11 would exclude finished hemp-derived cannabinoid products containing more than 0.4 milligrams per container of combined total THC and specified THC-like cannabinoids from the federal definition of hemp. - Certain other cannabinoid exclusions take effect Nov. 12. - Polyniak, founder of Kentucky Cannabis Company and Bluegrass Hemp Oil, entered Kentucky's original industrial hemp pilot program in 2014. - Polyniak says the industry should distinguish between naturally extracted full-spectrum hemp products and chemically converted intoxicating cannabinoids such as delta-8 and delta-9 THC. - Bluegrass Hemp Oil is the consumer-facing brand for Kentucky Cannabis Company, with retail locations in Lexington Green and historic Midway, plus online ordering.
The details: - Polyniak began working in CBD after his son developed epilepsy and experienced severe side effects from prescription medications. - His goal was to develop a consistently formulated full-spectrum CBD oil with measurable cannabinoid concentrations. - A March 10, 2014, Kentucky Department of Agriculture letter documents Polyniak's participation in one of six authorized industrial hemp pilot programs. - That work led to Genesis Blend Full Spectrum CBD Oil, a product formulated to retain naturally occurring hemp cannabinoids rather than rely only on purified CBD. - Kentucky Cannabis Company consolidated cultivation, extraction, formulation, manufacturing and laboratory testing into one Midway operation about six years ago. - Bluegrass Hemp Oil sells full-spectrum products including Genesis Blend and provides cannabinoid education and laboratory testing information. - The company's CBD oil guide explains product types and what consumers should check on labels. - Delta-8 THC occurs naturally in cannabis in very small quantities, but commercial concentrations are commonly made by chemically converting CBD. - Some hemp-derived delta-9 THC products also contain THC produced through conversion rather than direct extraction. - A 2023 peer-reviewed Journal of Cannabis Research study tested 53 hemp-derived delta-9 products. - Among 49 products assessed for cannabinoid origin, 24 showed evidence consistent with conversion from CBD. - The study did not establish how common conversion is across the broader market. - The FDA has warned about adverse events, potential reaction byproducts and pediatric exposures involving delta-8 products. - Polyniak says cannabinoid synthase genes help determine whether cannabis plants develop CBD-dominant or THC-dominant profiles. - Federal and state packaging rules vary by product category. - Polyniak says regulation should reflect those differences instead of treating every cannabinoid product as equivalent.
Between the lines: - Polyniak's argument is not just about THC limits. It is about whether regulators separate naturally derived hemp extracts from lab-converted intoxicating products. - The packaging issue broadens the debate beyond chemistry. Accessibility for older adults with arthritis or limited hand strength is also part of the consumer-safety discussion. - The new rule could force some full-spectrum products to prove they stay below the revised federal threshold, even if the THC is naturally occurring.
What's next: - Whether a full-spectrum product remains within the revised hemp definition will depend on its composition and the law's requirements. - Manufacturers with naturally derived hemp extracts will need to review cannabinoid content and compliance before the December deadline. - Consumers may see more emphasis on lab testing, labeling and product education as the rule takes effect. - Bluegrass Hemp Oil directs readers to more information about its products and Genesis Blend Full Spectrum CBD Oil.
The bottom line: - The coming federal hemp change could redraw the line between traditional full-spectrum CBD oils and converted intoxicating cannabinoid products, with Kentucky producers among those watching closely.
Disclaimer: This article was produced by AGP Wire with the assistance of artificial intelligence based on original source content and has been refined to improve clarity, structure, and readability. This content is provided on an “as is” basis. While care has been taken in its preparation, it may contain inaccuracies or omissions, and readers should consult the original source and independently verify key information where appropriate. This content is for informational purposes only and does not constitute legal, financial, investment, or other professional advice.
Sign up for:
Kentucky Political Observer
The daily local news briefing you can trust. Every day. Subscribe now.
Check Your Email!
We sent a one-time activation link to: .
Confirm it's you by clicking the email link.
If the email is not in your inbox, check spam or try again.
Welcome back!
is already signed up. Check your inbox for updates.